biosimilars

Poor test results for Roche cloud growth prospects
Yahoo/Reuters
Wed, 07/19/17 - 09:54 am
Roche
biosimilars
Rituxan
Herceptin
Avastin
Facing a critical August deadline, House passes bill to reauthorize FDA user fee programs
Endpoints
Thu, 07/13/17 - 09:19 am
FDA
user fees
generics
devices
biosimilars
The biosimilar pack is growing around Roche’s all-star trio, looking to rip into a $21B franchise
Endpoints
Wed, 07/12/17 - 10:36 am
Roche
biosimilars
Avastin
Herceptin
ABP 215
Amgen
MYL-14010
Mylan Labs
Rituxan
In latest setback, another Coherus partner bails out on Amgen biosimilar deal
Endpoints
Wed, 07/5/17 - 09:37 am
Coherus
Amgen
biosimilars
Daiichi Sankyo
CHS-0214
rheumatoid arthritis
Enbrel
Novartis scores second biosimilar approval in two weeks
BioPharma Dive
Thu, 06/29/17 - 09:43 am
Novartis
biosimilars
Enbrel
Europe
Sandoz
Erelzi
Roche
Rituxan
Coherus cuts staff after FDA red light
BioPharma Dive
Wed, 06/28/17 - 10:52 pm
Coherus Biosciences
layoffs
FDA
biosimilars
Amgen
Neulasta
FDA Rejects Pfizer's Anemia Drug Biosimilar
Xtalks
Tue, 06/27/17 - 11:50 pm
FDA
Pfizer
biosimilars
Epogen
Amgen
anemia
[video]Will AbbVie Outsmart Biosimilars, and Can Clovis Win the PARP Race?
Motley Fool
Tue, 06/27/17 - 09:45 am
AbbVie
biosimilars
Humira
Clovis Oncology
Rubraca
Novartis
Regeneron
Eylea
EMA Recommends New HCV, Cancer and MS Drugs for Approval
RAPS.org
Sat, 06/24/17 - 09:11 am
Europe
EMA
hepatitis C
multiple sclerosis
breast cancer
renal cell carcinoma
AbbVie
Maviret
Gilead Sciences
Vosevi
Biogen
Amgen
Samsung Bioepis
biosimilars
Humira
Novartis
Kisqali
EUSA
Fotivda
FDA rejects Pfizer's Epogen biosimilar for the second time
Fierce Pharma
Fri, 06/23/17 - 09:50 am
FDA
Pfizer
biosimilars
Epogen
Novartis wins another biosimilar round with an OK for its Rituxan copycat
Endpoints
Mon, 06/19/17 - 03:16 pm
Novartis
biosimilars
Rituxan
Roche
Sandoz
Amgen loses its bid to delay biosimilars as SCOTUS hands Novartis a victory
Endpoints
Mon, 06/12/17 - 09:24 pm
Amgen
Novartis
Supreme Court
biosimilars
Neulasta
FDA
Coherus Biosciences
FDA panel backs Pfizer biosim to blockbuster anemia meds from Amgen, Johnson & Johnson
Fierce Pharma
Mon, 05/29/17 - 12:00 pm
FDA
advisory panels
Pfizer
biosimilars
Amgen
Epogen
Procrit
anemia
JNJ
UK watchdog accuses Merck of restricting biosimilar competition
Drug Delivery Business News
Thu, 05/25/17 - 08:44 am
Merck
biosimilars
competition
UK
Remicade
Pfizer's Epogen biosim scores solid backing from FDA staff ahead of panel review
Fierce Pharma
Wed, 05/24/17 - 10:51 am
Pfizer
Epogen
biosimilars
FDA
advisory panels
Amgen
anemia
Sanofi’s insulin biosimilar wins EMA committee recommendation
Drug Delivery Business News
Mon, 05/22/17 - 09:36 am
Sanofi
insulin
biosimilars
EMA
Europe
Lispro
Key Humira patent goes down via IPR—but biosims makers shouldn't celebrate yet, analysts warn
Fierce Pharma
Thu, 05/18/17 - 12:09 am
Humira
patents
AbbVie
biosimilars
Novartis pushes further into pain with Durect deal
BioPharma Dive
Tue, 05/9/17 - 10:45 pm
Novartis
Durect
Sandoz
biosimilars
generics
Posimir
R&D
Amid sales growth, Roche plans defense from biosimilar threats
BioPharma Dive
Fri, 04/28/17 - 10:30 am
Roche
biosimilars
Rituxan
Herceptin
Avastin
U.S. top court grapples over making copycat biologics available sooner
Yahoo/Reuters
Wed, 04/26/17 - 09:39 pm
biosimilars
Neupogen
Amgen
Supreme Court

Pages